2015年度8月召开北京首届前列腺癌研讨会医学会议公告
会议日期：2015.08.08-2015.08.09
会议地点：北京
联系人：鄂女士（jane)
联系电话：024-31930319
E-mail：jane@pcsconference.com
传真：024-86085759
联系地址：辽宁省沈阳市皇姑区长江街134号
学分：I类2分
世纪科学国际癌症大会——2015首届前列腺癌研讨会将于2015年8月8 - 9日在中国北京举行。
大会旨在为前列腺癌研究提供一个从基础科学到临床应用的专属平台，促进国际交流，加强对外合作。本次大会设置了12个专题论坛，其中包括前列腺癌基础科学前沿进展、早期诊断、临床管理、手术治疗等领域。
目前已有来自近20个国家50余名代表确定参会和参加演讲，我们真诚的邀请您参加本次大会，大会还有报告机会和海报展示交流。演讲报名及论文摘要收录截止期临近，我们真诚地希望您能莅临参加并积极参与相关交流活动www.lindalemus.com。
关于前列腺癌研讨会日程，请参见：
PCS Global Cancer Conference
1st International Prostate Cancer Symposium – 2015
Theme: World Dreams of Early Diagnosis and Early Therapy of Prostate Cancer
1st International Lung Cancer Symposium – 2015
Theme: Advanced Early Diagnosis and Early Therapy of Lung Cancer
August 8-9, 2015 Place: Beijing, China
| Registration Day Day 0: Time: 8:30-22:00 (Whole day) Aug. 7, 2015 (Friday) Registration Place: Lobby of Conference Hotel | |
| Opening Ceremony Keynote Forum and Plenary Day 1: Time: 8:40-12:25 (Morning), Aug. 8, 2015 (Saturday) Conference Room: 2-1 | |
| 8:40-8:55 | Group Photo for All Delegates and Speakers |
| 9:00-9:15 | Opening Ceremony |
| 09:15-09:25 | Chair: Dr. Chiming Wei, Professor and Chief Scientist, Chongqing Academy of Science and Technology, China; President, American Nanomedicine Institute, USA Co-chair: Dr. Edwin Cheung, Professor, Faculty of Health Sciences, University of Macau, Macau SAR, China |
| 09:25-09:55 | Title: Clinical Implication of Molecular Profiling in Lung Cancer Dr. Zhaolin Xu, Professor, Department of Pathology, Dalhousie University, Canada |
| 09:55-10:25 | Title: Prostate Cancer Region Prediction using Hybrid Molecular and Optical Imaging for Targeted Bomarker Aalysis Dr. Frederic (Rick) D. McKenzie, Professor and Chair, Modeling, Simulation, & Visualization Engineering Dept. Joint Appointment, Electrical & Computer Engineering Dept, Old Dominion University, USA |
| 10:25-10:55 | Title: Functional Characterization and Molecular Mechanism of a FABP5-PPARγ-VEGF Signaling Axis Promoting Tumorigenicity in Prostatic Cancer Dr. Youqiang Ke, Professor & Director of Molecular Pathology, Dept. of Molecular & Clinical Cancer Medicine, The University of Liverpool, UK |
| 10:55-11:25 | Title: Genomic Analysis of Androgen Signaling in Prostate Cancer Cells Dr. Edwin Cheung, Professor, Faculty of Health Sciences, University of Macau, Macau SAR, China |
| 11:25-11:55 | Title: Genetic Markers for Prostate Cancer (PCa) in African Male Dr. Shingai Mutambirwa, Professor and Head of Department of Urology, Sefako Makgatho Health Sciences University, South Africa |
| 11:55-12:25 | Title: Circulating Tumor Cells in the Diagnosis and Monitoring of Breast Cancer Dr. Beiyun Chen, Associate Professor, Department of Pathology, Mayo Clinic, Rochester, MN, USA |
| 12:30-13:30 |
Lunch |
| Track 1: Basic Research and Clinical Diagnosis of Cancers Day 1: Time: 13:30-18:30 (Afternoon), Aug. 8, 2015 Conference Room: 2-1 | |
| 13:30-13:40 | Session Introduction Session Chair: Dr. Xiang-Dong Wang, Director and Senior Scientist, Nutrition and Cancer Biology Laboratory, Professor, Tufts University, USA Session Co-chair: Dr. Andrew A. Goldenberg, Professor Emeritus, Mechanical Engineering, Consulting Engineer, Electrical and Computer Engineering, University of Toronto, Canada |
| 13:40-14:05 | Title: Carotenoid Chemoprevention of Lung Cancer: What Lessons We Learned Dr. Xiang-Dong Wang, Director and Senior Scientist, Nutrition and Cancer Biology Laboratory, Professor, Tufts University, USA |
| 14:05-14:30 | Title: Bioengineering Three-dimensional Culture Model of Human Lung Cancer Cells for Screening EGFR Targeted Inhibitors Dr. Xiuli Wang, Professor, Hisitology and Embryology Department, Dalian Medical Univeristy, China |
| 14:30-14:55 | Title: FoxQ1 Overexpression Influences Poor Prognosis in NSCLC, Through Regulating EMT and Increasing Chemosensitivity Dr. Jianfei Huang, Deputy Director, Department of Pathology, Nantong University Affiliated Hospital, Nantong, Jiangsu, China |
| 14:55-15:20 | Title: Chemoprevention of Prostate Cancer by Kava Product Dr. Yaxiong Tang, Professor, Chengdu Institute of Biology, Chinese Academy of Sciences, China |
| 15:20-15:45 | Title: MRI-Guided Robot-Assisted Prostate Surgery Dr. Andrew A. Goldenberg, Professor Emeritus, Mechanical Engineering, Consulting Engineer, Electrical and Computer Engineering, University of Toronto, Canada |
| 15:45-16:00 | Coffee Break |
| 16:00-16:25 | Title: Anesthesia for Robotic Prostatectomy: Challenges, Management, and Safe Clinical Discharge Criteria from the Operating Room Dr. Menekse Oksar, Assistant Professor, Department of Anesthesiology and Reanimation, Mustafa Kemal University, Turkey |
| 16:25-16:50 | Title: Microvesicles in Cancer Pogression and Dagnosis Dr. Khalid Al-Nedawi, Assistant Professor, Department of Medicine, McMaster University and St. Joseph’s Healthcare, Canada |
| 16:50-17:15 | Title: Unraveling the Crosstalk between Circadian Rhythm, Metabolism and Autophagy in Determinming Prostate Cancer Cell Viability Dr. Benedetto Grimaldi, Team Leader, Drug Discovery and Development, Italian institute of technology, Italy |
| 17:15-17:40 | Title: AKR1C3 Overexpression may serve as a Promising Biomarker for Prostate Cancer Progression and Therapy Target Dr. Yuantong Tian, College of Basic Medical Sciences, Jilin University, China |
| 17:40-18:05 | Title: Identification of Specific DNA Methylation Sites on the Y Chromosome as Biomarker in Prostate Cancer Dr. Ying li Sun, Professor, Beijing Institute of Genomics, Chinese Academy of Sciences, China |
| 18:05-18:30 | Title: A Novel Tumor Metastasis Suppressor Gene LASS2/TMSG1 Interacts with Vacuolar ATPase through its Homeodomain Dr. Fei Pei, Clinical and Research Associate Professor, Department of Pathology, Health Science Center, Peking University, China |
| 19:00 | Welcome Banquet |
| Trake2: Advanced Research on Prostate Cancer and Lung Cancer Day 2: Time: 09:00-11:30 (Morning), Aug. 9, 2015 Conference Room: 2-1 | |
| 09:00-09:10 | Session Introduction Session Chair: Dr. John Mao, Senior Vice President and Head of Development, Foresee Pharmaceuticals, USA Session Co-chair: Dr. Yun Zhang, Assistant Research Scientist, Department of Urology, Institute for Health Innovation and Policy, University of Michigan, USA |
| 09:10-09:35 | Title: Rapid Development and Commercialization of a Proprietary Sustained-release Depot Formulation of Leuprolide for the Treatment of Advanced Prostate Cancer Dr. John Mao, Senior Vice President and Head of Development, Foresee Pharmaceuticals, USA |
| 09:35-10:00 | Title: Integrative Genetic and Epigenetic Analyses Identify Driver Long Noncoding RNAs in Prostate Cancer Dr. Housheng Hansen He, Assistant Professor, Department of Medical Biophysics, University of Toronto; Scientist, Princess Margaret Cancer Centre, University Health Network. Toronto, Canada |
| 10:00-10:25 | Title: The Impact of Regionalization of MIRP on Outcome in the US Dr. Yun Zhang, Assistant Research Scientist, Department of Urology, Institute for Health Innovation and Policy, University of Michigan, USA |
| 10:25-10:40 | Coffee Break |
| 10:40-11:05 | Title: Correlation of EGFR Expression, Gene Copy Number and Clinicopathological Status in NSCLC Dr. Rania Gaber, Department of Pathology, Faculty of Medicine, University of Alexandria, Egypt |
| 11:05-11:30 | Title: An Expression Signature at Quantec Analysis of Radiation-Induced Toxicity in Patients Receiving Stereotactic Body Radiotherapy(SBRT) for Lung Tumors Dr. Bixiu Wen, Chairman and Professor, Department of Radiation Oncology, The First Affiliated Hospital Sun Yat-sen University, Guangzhou, China |
| 12:30-13:30 | Lunch |
| Track 3: Prostate Cancer and Related Research Day 2: Time: 13:30-16:50 (Afternoon), Aug. 9, 2015 Conference Room: 2-1 | |
| 13:30-13:40 | Session Introduction Session Chair: Dr. Finn Edler von Eyben, Center of Tobacco Control Research, Denmark Session Co-chair:Dr. Chiming Wei, Professor and Chief Scientist, Chongqing Academy of Science and Technology, China; President, American Nanomedicine Institute, USA |
| 13:40-14:05 | Title: Advanced Nanomedicine in Cancer Diagnosis and Treatment Dr. Chiming Wei, Professor and Chief Scientist, Chongqing Academy of Science and Technology, China; President, American Nanomedicine Institute, USA |
| 14:05-14:30 | Title: New Trends in Radiotherapy for Prostate Cancer Dr. Finn Edler von Eyben, Center of Tobacco Control Research, Denmark |
| 14:30-14:55 | Title: Behavioral Stress, Apoptosis Network and Personalized Therapy for Advanced Prostate Cancer Dr. George Kulik, PhD Associate Professor of Cancer Biology; Department of Life Sciences, Chair, College of Science & General Studies; Alfaisal University, KSA, Department of Cancer Biology, Wake Forest University Health Sciences, USA |
| 14:55-15:20 | Title: Salvage Brachytherapy in Prostate Cancer after Failure from Radiation Treatment Dr. Ivan Henriquez, Radiation Oncology, Medical Staff, University Hospital Sant Joan, Spain |
| 15:20-15:35 | Coffee Break |
| 15:35-16:00 | Title: Utility of Immunohistochemical Staining of P63 and Amacr in Prostate Neoplasm: A Cross Sectional Stufy. Dr. Ankush Nayyar, Third year resident, Department of pathology, IMS And SUM Hospital, Bhubaneswar, India |
| 16:00-16:25 | Title: High Intensity Focused Ultrasound for Prostate Cancer Treatment - status Quo 2015 Dr. Vyacheslav Solovov, Professor, Head of the Interventional Oncology Department, Samara Oncology Center, Russia |
| 16:25-16:50 | Title: Cost-effectiveness Analysis of Treatments for Low Risk and Intermediate Risk Localised Prostate Cancer Dr. Chunhuan Lao, PhD Candidate in Health Economics, Waikato Clinical Campus, The University of Auckland, New Zealand |
更多医学会议资讯相关推荐：
